Company: AIP
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001667011-25-000022
Chunk: 247

Company: Arteris, Inc.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 8
Chunk 247
---
 are commensurate with the amounts paid for initial contracts, the deferred incremental costs for initial contracts and for term extensions are recognized over the respective contract terms. Total capitalized direct commission costs were as follows (in thousands):As ofMarch 31,2025December 31,2024Short-term commission capitalized in prepaid expenses and other current assets$2,306 $2,311 Long-term commission capitalized in other assets1,673 1,789 Total$3,979 $4,100 Amortization of capitalized sales commissions was $0.8 million and $0.9 million for the three months ended March 31, 2025 and 2024, respectively, and are included in sales and marketing expense in the unaudited condensed consolidated statements of operations.

4.    NET LOSS PER SHARE

The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share data):Three Months EndedMarch 31,20252024Numerator:Net loss$(8,121)$(9,403)Denominator:Weighted-average shares outstanding, basic and diluted40,853,048 37,709,058 Net loss per share, basic and diluted$(0.20)$(0.25)Since the Company was in a loss position for all periods presented, the diluted earnings per share is equal to the basic earnings per share as the effect of potentially dilutive securities would have been antidilutive.The following table summarizes the potentially dilutive securities that were excluded from the calculation of diluted earnings per share because they would be anti-dilutive:As ofMarch 31, 2025March 31, 2024Stock options2,331,645 2,600,072 Restricted stock units5,087,569 5,877,561 Restricted common shares issued for business combination234,859 234,859 Shares committed under the 2021 ESPP83,398 — Total7,737,471 8,712,492 

11

5.    INVESTMENTS

The following tables summarize the fair value and amortized cost of the Company’s cash equivalents and available-for-sale securities by major security type (in thousands):As of March 31, 2025Amortized CostUnrealized GainsAggregate Fair ValueAssets: U.S. government agency securities$15,303 $6 $15,309 Money market funds13,